This was also confirmed by immunohistochemistry (Fig. 4g; Supplementary Fig. 8c) and suggests that the availability of SHH signaling peptide is greatly enhanced in vivo, thus rendering the tumor cells competent to receive a reverse paracrine signal. This evidence concerns the gene SHH and neoplasm.